Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Bayer is due to present results from the phase 1/2 SOHO-01 study of BAY 2927088 as a second-line therapy for HER2-altered NSCLC at the World Conference on Lung Cancer (WCLC) in San Diego on 9th ...

Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.

Targeted chemotherapy and genomics testing have made treatment outcomes much better. There are drugs with fewer side effects ...